1. Organic Sales, Operating EPS, Free Cash Flow, and Operating EBITDA are non-GAAP measures. See page 6 for further discussion. 2. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and Africa. 3. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 7 for further discussion. 4. Not meaningful. INDIANAPOLIS, Feb. 3, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for th ...

Group 1 - The core viewpoint of the news is that Henan Agricultural University has demonstrated strong capabilities in agricultural technology innovation and achievement transformation, with a total signing amount of 38.63 million yuan during a recent collective signing ceremony for new wheat and corn varieties and technologies [1] - The cumulative amount of research achievement transformation by Henan Agricultural University’s College of Agriculture is expected to reach 72.2 million yuan by 2025, indicating significant progress in agricultural research commercialization [1] - The signing involved 17 research institutions and seed companies, covering multiple crop varieties and key technologies, emphasizing the university's commitment to national food security and agricultural modernization [1] Group 2 - Henan Agricultural University has achieved breakthroughs in wheat and corn research, with the newly developed corn variety 'MY73' being promoted over an area of 20 million mu for two consecutive years, ranking among the top in the country [2] - The university's efforts in technology transfer and collaboration with local governments and enterprises mark a new phase in their partnerships, enhancing the integration of industry, innovation, and talent [2] - The university aims to continue leveraging its academic and research strengths to expand cooperation with enterprises, contributing to the development of modern agricultural technology and rural revitalization [2]

Core Viewpoint - Corteva (CTVA) is splitting its operations into two segments, allowing investors to focus on a pure seed play, which is a rare opportunity in the market [1] Group 1: Company Overview - Corteva is undergoing a strategic split of its operations, which will provide investors with a distinct investment opportunity in the seed sector [1] Group 2: Market Context - The seed sector is highlighted as a unique investment opportunity, with limited comparable options available in the market [1]

Group 1 - Corteva (CTVA) is splitting its two segment operations, allowing investors to focus on a pure seed play, which is a rare opportunity in the market [1] - The analyst has over a decade of experience in financial markets, primarily in hedge funds, with a focus on sectors like tech, SaaS, cloud, energy, and minerals [1] Group 2 - The energy and minerals sectors are highlighted as offering incredible growth opportunities and are actively researched due to the frequent news updates [1]

Company Performance - Biofrontera Inc. experienced a price drop to $0.05, marking a decrease of approximately 36.07%, potentially due to market dynamics or operational challenges [2][8] - IAC Inc. saw its stock decline to $0.60, a 33.31% drop, attributed to the recent spin-off of its subsidiary, Angi Inc., and subsequent market adjustments [3][8] - OmniAb, Inc. had its stock price fall to $0.08, a decrease of 44.83%, indicating investor concerns over growth prospects or market competition [4][8] - S&W Seed Company experienced a price drop to $0.11, reflecting a 48.59% decrease, possibly due to its decision to voluntarily delist from The Nasdaq Capital Market [5] - MingZhu Logistics Holdings Limited saw a significant decline to $0.17, an 83.53% drop, related to operational challenges and market competition in the logistics sector [6] Market Trends - The price movements of these companies reflect a combination of company-specific developments, sectoral challenges, and broader market trends [7]

Corteva Investor Call Summary Company Overview - **Company**: Corteva (NYSE: CTVA) - **Date of Call**: October 01, 2025 - **Key Speakers**: Chuck Magro (CEO), David Johnson (CFO) Core Points and Arguments Financial Performance - Corteva's 2025 full-year guidance remains intact, with expectations for 2026 EBITDA at approximately $4.1 billion at the midpoint, consistent with prior expectations [4][5] - Since its establishment as a standalone public company in 2019, Corteva has achieved an 11% CAGR in annual operating EBITDA and increased EBITDA margins by over 700 basis points [6] - The company has returned $7 billion in cash to shareholders and delivered a total shareholder return (TSR) of about 200% during the same period [6] Product Development and Innovation - Corteva launches around 500 new products annually, with new products expected to generate over $5 billion in additional revenue [7] - The company is a leader in biologicals and is developing new growth platforms, including biofuels, hybrid wheat, and gene editing, which are projected to be multibillion-dollar revenue streams [7][8] Strategic Separation Announcement - Corteva plans to separate into two companies: one focused on crop protection (CP) and the other on seed business (SpinCo) [11] - The separation is driven by the belief that both businesses will benefit from operational freedom and the ability to innovate independently [11][12] - The separation is expected to maximize long-term value for shareholders, farmers, and employees, with manageable dis-synergies anticipated [13] Market Outlook - The crop protection market is expected to return to growth, with Corteva's CP business outperforming the market through recent competitive conditions [15] - The CP market values effective, differentiated technology, particularly in the expanding biological segment [16] - The company anticipates that being a pure play in crop protection will enhance operational efficiency and innovation [17] Future Growth and Opportunities - SpinCo is expected to expand into new markets beyond corn and soybeans, including fruits, vegetables, and other row crops, leveraging advanced genetics [19] - The hybrid wheat technology, launching in 2027, is projected to increase yields by 10% to 20%, representing a significant revenue opportunity [28] - Both companies will focus on capital allocation strategies designed to maximize growth and value creation [29] Organizational Structure and Leadership - Upon separation, Greg Page will become Chair of the CP business (Nucor Teva), while Chuck Magro will serve as CEO of SpinCo [30] - The separation is designed to ensure continuity in leadership and leverage the expertise of both companies [30] Financial and Legal Considerations - The separation is intended to qualify as a tax-free spin-off for U.S. tax purposes, with both companies expected to maintain investment-grade credit ratings [31] - Legacy liabilities, including historical DuPont pension plans and PFAS obligations, will remain with the CP business [86][101] Additional Important Insights - The company has a strong pipeline with over $9 billion in potential new products, including a novel fungicide targeting a significant pest problem in Brazil [22] - Corteva's CP business has increased its EBITDA margins by 180 basis points since 2020, while many peers have seen declines [23] - The separation is expected to be completed in 2026, with a focus on minimizing disruption and complexity during the transition [33] This summary encapsulates the key points discussed during the Corteva investor call, highlighting the company's strategic direction, financial performance, and future growth opportunities.

Core Viewpoint - The province is initiating inspections on autumn crop seeds to combat counterfeit and substandard products, ensuring the safety of seeds for the upcoming season [1] Group 1: Inspection Focus - The inspections will primarily target vegetable seeds and other autumn and winter crop seeds [1] - Key areas for inspection include seed trading markets, retail stores, supply points, and online platforms [1] Group 2: Inspection Content - The inspection will cover seed quality, authenticity, labeling, and compliance with usage instructions [1] - It will also assess the status of seed production, operation, and sales entities, as well as variety registration [1] Group 3: Compliance and Enforcement - Any illegal activities discovered during inspections will be promptly investigated and dealt with according to the law [1] - Non-compliant seeds and operators will face legal consequences, and results will be communicated in a timely manner [1] Group 4: Quality Assurance - The province will conduct tests on sampled vegetable seeds for germination rates and variety purity [1] - The legality and completeness of labels and usage instructions for seeds sold in the market will be verified [1] Group 5: Inspection Procedures - The inspections will adhere to the "double random, one public" principle, ensuring a standardized process [1] - Proper documentation and evidence collection will be maintained to ensure the integrity and reliability of the inspection process [1]

Summary of Dabeinong (002385.SZ) Earnings Review Company Overview - **Company**: Dabeinong (002385.SZ) - **Industry**: Agriculture in China - **Market Cap**: Rmb17.5 billion / $2.5 billion - **Enterprise Value**: Rmb25.8 billion / $3.6 billion - **Current Price**: Rmb4.23 - **12-Month Price Target**: Rmb8.00 - **Upside Potential**: 89.1% [1][2][6] Key Financial Highlights - **1H25A Net Profit**: Rmb235 million, EPS of Rmb0.055/share, compared to a loss of Rmb0.036/share in 1H24A [1] - **Recurring Net Profit**: Rmb196 million, versus a loss of Rmb244 million in 1H24A [1] - **Revenue Growth**: 4% YoY to Rmb13,559 million in 1H25A [40] - **Gross Profit**: Increased by 12% YoY to Rmb1,915 million [40] - **No Final Dividend Declared**: Consistent with the previous year [1] Earnings Estimates Revisions - **2025E Recurring Earnings**: Revised down by 25% due to lower hog pricing assumptions [2] - **2026E Recurring Earnings**: Revised down by 4% [2] - **2027E Recurring Earnings**: Revised down by 9% [2] Segment Performance - **Feed Operations**: Contributed 56% of total gross profit; gross profit per ton was Rmb417, down 10% YoY [23] - **Hog Farming**: Contributed 29% of total gross profit; total unit cost of market hog decreased by 16% YoY [26] - **Traditional Seeds**: Contributed 9% of total gross profit; driven by higher sales volume and unit gross profit [27] - **Biotech Seeds**: Expected to generate Rmb116 million in revenue in 2025E, with a potential increase to Rmb532 million in 2026E [21] Market Dynamics - **Hog Pricing Outlook**: Expected to improve to Rmb16.5/kg in 2026E, up from Rmb14.8/kg in 1H25A [20] - **Biotech Seed Penetration**: Anticipated to reach 7% in the 2024/25 planting season, lower than previous estimates [21] - **Traditional Seed Market**: Potential market gains in Southwestern regions due to product promotion [22] Cash Flow and Balance Sheet - **Operating Cash Flow**: Turned positive in 1H25A, compared to negative Rmb190 million a year ago [34] - **Free Cash Flow**: Negative Rmb363 million in 1H25A, an improvement from negative Rmb593 million in 1H24A [34] - **Net Debt**: Rmb8.14 billion as of end of 1H25A, with net gearing at 93% [35][36] Valuation and Risks - **Valuation Methodology**: Based on average near-term and long-term valuations, with a target price implying a P/E of 34x for 2025E [37] - **Key Risks**: Include uncertainty in hog prices, lower-than-expected feed consumption demand, and slower government plans for GM seed commercialization [38] Conclusion - **Investment Recommendation**: Maintain Buy rating on Dabeinong with a target price of Rmb8.00, reflecting strong potential upside based on market positioning and growth in biotech seeds [2][37]

Summary of Longping High-Tech (000998.SZ) Earnings Call Company Overview - **Company**: Longping High-Tech (000998.SZ) - **Industry**: Agriculture, specifically seed production - **Market Cap**: Rmb13.3 billion / $1.9 billion - **Enterprise Value**: Rmb24.4 billion / $3.4 billion - **12-Month Price Target**: Rmb12.00, indicating an upside of 18.9% from the current price of Rmb10.09 Key Financial Highlights - **1H25A Results**: - Net loss of Rmb164 million, compared to a profit of Rmb111 million in 1H24A - Recurring net loss of Rmb284 million, up from Rmb62 million a year ago - Revenue decreased by 16% YoY to Rmb2,166 million - Gross profit declined by 4% YoY to Rmb786 million - No interim dividend declared, consistent with the previous year [1][34] Earnings Estimates Revisions - **2025E**: Recurring earnings estimates revised down by 20% - **2026E**: Revised down by 5% - **2027E**: Revised down by 2% - Expected recurring net profit to decline by 30% in 2025E, but improve by 80% in 2026E, driven by rice seeds and Brazil corn operations [2][38] Segment Performance - **Domestic Corn Seeds**: - Gross profit down 40% to Rmb6.4/kg due to lower average selling price (ASP) and higher unit costs - Sales volume significantly decreased by 69% YoY [25][35] - **Hybrid Rice Seeds**: - Stable gross profit, maintaining a 20% market share in the domestic market - Expected to benefit from high disease resistance and premium pricing [22][26] - **Brazil Operations**: - Gross profit improved nearly 4.9x YoY, driven by lower high-cost inventory and stable pricing - Sales volume improved for the 24/25 Safrinha season [28][35] - **Biotech Seeds**: - Expected to reach 10% penetration in the domestic market by 2025E, potentially boosting total profit by 4% in 2025E and 13% in 2026E [24][29] Cash Flow and Balance Sheet - **Operating Cash Flow**: Negative Rmb938 million, consistent with seasonal patterns - **Free Cash Flow**: Negative Rmb1,169 million for 1H25A - **Net Debt**: Rmb8.38 billion with a net gearing ratio of 86%, down from 101% at the end of 2024A [30][34] Valuation and Risks - **Valuation Methodology**: - Near-term valuation based on a P/E of 30x for 2026E - Long-term valuation includes a P/E of 20x for traditional seeds by 2030E - Target price of Rmb12.0 implies a P/E of 30x for 2026E and 22x for 2027E [31][41] - **Key Risks**: - Slower-than-expected government approval for GM seed commercialization - Potential downturn in hybrid rice pricing cycle - Uncertainty in the recovery of the Brazil business [32][40] Conclusion - Longping High-Tech remains a dominant player in China's seed industry, with significant potential in biotech seeds. Despite current challenges, the company is expected to recover in the coming years, supported by improvements in rice seeds and Brazil operations. The investment thesis remains positive with a "Buy" rating based on future growth prospects and market positioning [38][41]

Corporate Finance - Godrej Seeds and Genetics 正在考虑首次发行本地货币债券 [1] - Godrej Seeds and Genetics 是印度历史最悠久的集团公司之一 [1]